Page last updated: 2024-09-04

cinacalcet and Milk-Alkali Syndrome

cinacalcet has been researched along with Milk-Alkali Syndrome in 146 studies

Research

Studies (146)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	37 (25.34)	29.6817
2010's	81 (55.48)	24.3611
2020's	28 (19.18)	2.80

Authors

Authors	Studies
Kaku, K; Kamei, S; Kaneto, H; Kimura, T; Kohara, K; Mune, T; Nakanishi, S; Obata, A; Sanada, J; Shimoda, M; Tatsumi, F	1
Doumas, A; Goropoulos, A; Karras, S; Siolos, A; Terzaki, A; Tigas, S; Tzotzas, T; Zaramboukas, T	1
Aindow, A; Isherwood, L; Mughal, MZ; Ramakrishnan, R; Wade, L	1
Hao, Y; Ji, W; Lei, Z; Shi, N; Yu, L; Zhang, X	1
Capuano, B; Conigrave, AD; Dinh, LV; Gregory, KJ; Josephs, TM; Keller, AN; Leach, K; Zhang, F	1
Demir, S; Dilek, E; Gürkan, H; İnan, M; Kökenli, F; Özgüç Çömlek, F; Sezer, A	1
Blanchard, C; Caillard, C; Figueres, L; Frey, S; Goronflot, T; Gourraud, PA; Hourmant, M; Kerleau, C; Mirallié, É; Wargny, M	1
Cao, Y; Sun, H; Wang, Z; Xiong, Y	1
Bibik, E; Dobreva, E; Eremkina, A; Gorbacheva, A; Krupinova, J; Mirnaya, S; Mokrysheva, N	1
Maguire, D; Rasool, I; Shah, PM	1
Dejkhamron, P; Intachai, W; Kantaputra, P; Ketudat Cairns, JR; Khorana, J; Ngamphiw, C; Olsen, B; Tongsima, S; Watcharachan, K; Wejaphikul, K	1
Fung, MM; Lang, BH; Lui, DT; Tam, DS	1
Ahmad, HM; Shafiq, MU; Shaukat, M	1
Chen, H; Disharoon, M; Fazendin, J; Gillis, A; Lindeman, B; McLeod, MC; McMullin, JL; Ong, S; Price, G; Stidham, G; Wang, R	1
Faiq, S; Hu, T; Ku, G; Lavelle, K; Shoback, D	1
Ansori, ANM; Scappaticcio, L; Trimboli, P	1
Koca, SB	1
Denoncin, C; Godefroid, N; Limaye, N; Pirson, Y; Scheers, I; Sokal, E; Stephenne, X	1
Barreto, FC; Bucharles, SGE; Riella, MC	1
Hasegawa, M; Koike, J; Koitabashi, K; Shibagaki, Y; Suzuki, T; Uehara, A; Yamamoto, Y; Yazawa, M	1
Bränström, R; Koman, A; Nilsson, IL; Ohlsson, S; Pernow, Y	1
Bottoni, G; Foppiani, L; Piccardo, A	1
Lopes de Lima, M; Mazzali, M; Rivelli, GG	1
Aschenbach, R; Biermann, A; Freesmeyer, M; Kloos, C; Lupp, A; Mtuka-Pardon, G; Seifert, P; Werner, C; Wolf, G	1
Bestard, O; Codina, S; Coloma, A; Cruzado, JM; Francos, J; García-Barrasa, A; Manonelles, A; Melilli, E; Montero, N; Moreno, P; Torregrosa, JV	1
Jatoi, A; Loprinzi, CL; Onitilo, AA; Sheehan, MT; Wermers, RA	1
Bränström, R; Koman, A; Nilsson, IL; Pernow, Y	1
Bayliss, AL; Codner, G; Gorvin, CM; Hannan, FM; Kooblall, KG; Stevenson, M; Stewart, M; Stokes, VJ; Teboul, L; Thakker, RV; Wells, S	1
Alfadhli, EM	1
Bailey, M; Manners, R; McDougall, C; Timmons, JG	1
Bachmeyer, C; Belaube, N; Gauthé, M; Haymann, JP; Loi, V; Wendum, D	1
Abdelmoneim, SS; Gopinath, C; Pattan, V; Singh, B; Sundaresh, V	1
Misiorowski, W; Zgliczyński, W	1
Biain Ciganda, A; Bustinza Beaskoetxea, Z; Fernández Matia, G; Gonzalo García, I; Martín Macías, MLA; Martínez Guisasola, J; Robles Fradejas, M; Ruiz Pérez, E	1
Brown, SD; Cox, RD; Gorvin, CM; Hannan, FM; Hough, TA; Howles, SA; Nesbit, MA; Paudyal, A; Piret, SE; Stewart, M; Thakker, RV; Wells, S	1
Fyssa, L; Goumenos, DS; Ntrinias, T; Papachristou, E; Papasotiriou, M; Savvidaki, E; Zavvos, V	1
Kapczynski, A; Kim, J; Ross, JS	1
Ohno, Y; Oshima, J; Otsuka, K	1
Breitwieser, GE; Gorvin, CM; Hannan, FM; Krishnamurthy, SB; Metpally, R; Overton, JD; Reid, JG; Stokes, VJ; Thakker, RV	1
Ago, T; Arakawa, S; Kimura, S; Kitazono, T; Ohya, Y; Osaki, M; Sakai, S; Yasuda, C	1
Bellasi, A; Cancarini, G; Cozzolino, M; Esposito, C; Genderini, A; Guastoni, CM; Locatelli, F; Malberti, F; Messa, P; Ondei, P; Pontoriero, G; Teatini, U; Vezzoli, G	1
Arif, H; Babich, M; Beg, M; Christou, A; Sial, M; Talwar, A; Zahid, S	1
Carda, S; Da Costa F de Frias Pinto, A; Grana, E	1
Cetani, F; Ferrari, F; Marcocci, C	1
Cetani, F; Marcocci, C; Saponaro, F	1
Ando, T; Iiri, T; Kawakami, A; Kikuchi, Y; Makita, N; Manaka, K; Matsumoto, N; Mitani, K; Nangaku, M; Niwa, T; Ogawa, T; Ootaki, M; Sato, J; Takeba, Y	1
Alexander, RT; Beggs, MR; Chen, XZ; Dimke, H; Flockerzi, V; Lee, JJ; Liu, X; O'Neill, D; Weissgerber, P	1
Fujita, M; Iiri, T; Ito, N; Kinoshita, Y; Makita, N; Manaka, K; Nangaku, M; Sato, J	1
Han, KH; Han, SY; Jo, HA; Jun, H; So, YK	1
Borchhardt, K; Cohen, G; Hörl, WH; Raupachova, J	1
Colloton, M; Henley, C; Martin, D; Scully, S; Shatzen, E; Starnes, C; Wiemann, B	1
Domínguez Quintero, ML; Ferrer Castillo, MT; García Soblechero, E; González Fuentes, C; Jiménez Crespo, B	1
Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; London, GM; Mahaffey, KW; Modafferi, DM; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC	1
Ogrin, C	1
Barros, X; Torregrosa, JV	1
Bravo, J; Crespo, J; Díaz, JM; García, MR; Gentil, MÁ; Gómez Alamillo, C; Gómez, G; Gutiérrez Dalmau, A; Jiménez, VL; Jimeno, L; Morales, E; Rodríguez Benot, A; Romero, R; Sáez, MJ; Torregrosa, JV	1
Drake, WM; Hanson, PL; Jones, P; Pittaway, JF; Srirangalingam, U	1
Buonomano, P; Circelli, L; Colao, A; Del Prete, M; Di Somma, C; Faggiano, A; Marciello, F; Marotta, V; Modica, R; Ramundo, V; Rubino, M; Sciammarella, C; Vitale, M	1
Barros, X; Fuster, D; Oppenheimer, F; Paschoalin, R; Perlaza, P; Pons, F; Rubello, D; Torregrosa, JV	1
Cooper, K; Deng, H; Evenepoel, P; Holdaas, H; Messa, P; Mourad, G; Olgaard, K; Rutkowski, B; Schaefer, H; Torregrosa, JV; Wuthrich, RP; Yue, S	1
Baorda, F; Campo, MR; Cignarelli, M; Cinque, L; Conserva, A; Guarnieri, V; Lamacchia, O; Mastromatteo, E; Scillitani, A	1
Dochez, V; Ducarme, G	1
Crouzeix, G; Kerlan, V	1
Armanini, D; Bordin, L; Camozzi, V; Donà, G; Iacobone, M; Mian, C; Sabbadin, C	1
Bilezikian, J; Bone, H; Gurevich, A; Khan, A; Lakatos, P; Misiorowski, W; Rozhinskaya, L; Tóth, M; Trotman, ML	1
Brardi, S; Cevenini, G; Ponchietti, R; Romano, G; Verdacchi, T	1
Borchhardt, K; Gessl, A; Thiem, U	1
Canaff, L; Cole, DE; Hendy, GN; Lee, BS; Mäkitie, O; Tenhola, S; Välimäki, MJ; Valta, H; Wong, BY	1
Bestard, O; Cruzado, JM; Francos, J; García-Barrasa, A; Gómez-Vaquero, C; Grinyó, JM; Mast, R; Moreno, P; Polo, C; Revuelta, I; Taco, O; Torras, J; Torregrosa, JV	1
Drüeke, TB; Fukagawa, M	1
Babinsky, VN; Gorvin, CM; Hannan, FM; Hanyaloglu, AC; Howles, SA; Hu, J; Nesbit, MA; Rust, N; Spiegel, AM; Thakker, RV	1
Babinsky, VN; Gorvin, CM; Hannan, FM; Howles, SA; McKenna, MJ; Nesbit, MA; Richardson, T; Rogers, A; Rust, N; Thakker, RV	1
Durlik, M; Gałązka, Z; Ważna-Jabłońska, E	1
Alsaygh, N; Bartlett, AM; Luttrell, L; Mathews, JW; Winchester, R	1
Katagiri, M; Miura, D; Nakashima, N; Ohishi, H; Shimazaki, R; Takahashi, S; Takeuchi, Y; Tominaga, Y	1
Aitken, E; Al-Moasseb, Z	1
Bahner, U; Brandl, M; Nies, C; Schmidt-Gayk, H	1
Cointault, O; Durand, D; Esposito, L; Gandia, P; Gennero, I; Guitard, J; Kamar, N; Lavayssière, L; Rostaing, L; Spataru, L	1
Akinci, B; Comlekci, A; Tankurt, E	1
Clark, OH; Evenepoel, P; Triponez, F; Vanrenthergem, Y	1
Kebig, A; Mohr, K	1
Bergua, C; Campistol, JM; Fuster, D; Gutierrez-Dalmau, A; Oppenheimer, F; Torregrosa, JV	1
Bjerknes, R; Netelenbos, C; Raeder, H; Shaw, N	1
Borchhardt, KA; Haas, M; Heinzl, H; Hörl, WH; Mayerwöger, E; Sunder-Plassmann, G	1
Bos, WJ; Bouman, K; Braun, J; Brink, H; Carter, D; Frazão, JM; Graf, H; Macário, F; Maduell, F; Messa, P; Pontoriero, G; Reichel, H; Saha, H; Torregrosa, V; von Albertini, B; Wilkie, M; Yaqoob, M; Zani, VJ	1
Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B	1
de Boer, H; Groot, I; Hermus, A; Horjus, C; Kovacs, CS; Telting, D; van Setten, P; van Sorge, A	1
Shaw, NJ; Stanley, S	1
de Francisco, AL; Piñera, C	1
Adam, MA; Olson, JA; Untch, BR	1
Shaheen, FA; Souqiyyeh, MZ	1
Błazejewska, A; Flisiński, M; Manitius, J; Pypkowski, J	1
Padmanabhan, H	1
Abdellatif, A; Fanari, Z; Haque, W; Kadikoy, H; Pacha, O	1
Andres, A; Gutierrez, E; Morales, E	1
Alon, US; VandeVoorde, RG	1
Copley, JB; Germain, M; Katznelson, S; Pankewycz, O; Shah, T; Sprague, SM; Stern, L; Turner, SA; Wang, O	1
Bilezikian, JP; Bolognese, MA; Borofsky, M; Cheng, S; Peacock, M; Scumpia, S; Shoback, D; Sterling, LR	1
Aalten, J; Hoitsma, AJ; Wetzels, JF	1
Chamberlain, CE; Cho, ME; Duan, Z; Mannon, RB; Reynolds, JC; Ring, MS	1
Cuxart Pérez, M; Picazo Sánchez, M; Sans Lorman, R; Sardà Borroy, C	1
Arranz Martín, A; Azcárate Villalón, A; Carraro, R; Gómez Pan, A; Luque Ramírez, M; Marazuela Azpíroz, M; Paniagua Ruiz, A; Santana Durán, B	1
Pestana Vasconcelos, M; Pinho, LR; Ribeiro Santos, MJ	1
Alfieri, C; Brezzi, B; Messa, P	1
Colao, A; Coppola, A; Di Somma, C; Faggiano, A; Gasperi, M; Lombardi, G; Panico, F; Ramundo, V; Savastano, S; Severino, R; Vuolo, L	1
Bravo Soto, J; Esteban de la Rosa, RJ; Fernández Castillo, R; Fernández Gallegos, R; Oliva, N; Vaquero, E	1
Attaf, D; Boulanger, H; Flamant, M; Fouqueray, B; Glotz, D; Haymann, JP; Mansouri, R; Mercadal, L; Metivier, F	1
Casanueva, FF; García López, JM; García Vázquez, M; Prieto Tenreiro, AM; Puñal Rodríguez, JA	1
Banti, C; Cetani, F; Chiavistelli, S; Cianferotti, L; Marcocci, C; Pinchera, A; Saponaro, F; Viccica, G; Vignali, E	1
Cifuentes, M; Mattar, P; Reyes, M; Rothe, HM; Shapiro, WB	1
Abreu, C; Castro, JC; Díez, JJ; Iglesias, P	1
Jacobs, L; Koek, HL; Samson, MM; Verhaar, HJ	1
Youssef, D	1
Amdahl, M; Cozzolino, M; Goldsmith, D; Ketteler, M; Khan, S; Martin, KJ; Marx, S; Sharma, A; Wolf, M	1
Ferrer, J; Oriola, J; Torres Grajales, JL; Tundidor Rengel, D; Webb, SM	1
Hong, L; Nance, M; Newton, H	1
McCaffrey, P; Wallace, HJ; Wallace, IR	1
Bellamy, J; Janklewicz, P; Rostoker, G	1
Tominaga, Y	1
Cai, MM; Holt, SG; McMahon, LP; Smith, ER; Williams, DS	1
Barros, X; Campistol, JM; Durán, CE; Paschoalin, RP; Torregrosa, JV	1
Barros, X; Campistol, JM; Durán, CE; Paschoalin, RP; Sánchez-Escuredo, A; Torregrosa, JV	1
Franceschini, N; Joy, MS; Kshirsagar, A	1
Drüeke, TB	2
Marti, HP; Schwarz, AA; Serra, AL; Wick, FH; Wüthrich, RP	1
Boulanger, H; Fouqueray, B; Glotz, D; Haymann, JP; Mansouri, R; Metivier, F; Sarfati, E	1
Abbassi, A; Chuong, VT; de Vernejoul, MC; Guédon, C; Roueff, S; Saint Georges, M; Ureña Torres, P	1
Apostolou, T; Damianou, L; Drakopoulos, S; Hadjiconstantinou, V; Kotsiev, V	1
Torres, PU	1
Blessios, G; Gundroo, A; Karam, J; Kohli, R; Laftavi, M; Leca, N; Min, I; Pankewycz, O; Sridhar, N; Venuto, R	1
de Boer, H; Hamdy, NA; Hermus, AR; Karperien, M; Timmers, HJ	1
Lang, B; Lo, CY	1
Szmuilowicz, ED; Utiger, RD	1
Bilezikian, JP; Silverberg, SJ	1
Shelly, MA; Sloand, JA	1
Bruns, DE; D'Amour, P; Hanks, JB; Henrich, LM; Levine, MA; Rogol, AD	1
de Jong, GM; Gregoor, PS	1
Prié, D	1
Colin Forfar, J; Tilling, L	1
Bilezikian, JP; Faiman, C; Klassen, P; Olson, KA; Peacock, M; Rubin, MR; Schwanauer, LE; Shoback, DM; Silverberg, SJ; Smallridge, RC	1
Bucci, CM; Howard, RJ; Kaplan, B; Meier-Kriesche, HU; Schold, JD; Srinivas, TR; Womer, KL	1
Festen-Spanjer, B; Haring, CM; Koster, JB; Mudde, AH	1
Bergua, C; Cofán, F; Oppenheimer, F; Torregrosa, JV	1
Fukagawa, M; Komaba, H	1
Block, GA; Bushinsky, DA; Chertow, GM; Chi, EM; Sugihara, J; Turner, SA; Zeig, S	1

Reviews

23 review(s) available for cinacalcet and Milk-Alkali Syndrome

Article	Year
Effective long-term management of parathyromatosis-related refractory hypercalcemia with a combination of denosumab and cinacalcet treatment. Hormones (Athens, Greece), 2022, Volume: 21, Issue:1 Topics: Bone Density; Cinacalcet; Denosumab; Humans; Hypercalcemia; Hyperparathyroidism; Male	2022
Different treatment strategies in primary hyperparathyroidism during pregnancy. Endocrine, 2022, Volume: 77, Issue:3 Topics: Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Parathyroidectomy; Pregnancy; Pregnancy Complications	2022
Cinacalcet therapy in a child with novel homozygous CASR p.Glu353Lys mutation causing familial hypocalciuric hypercalcemia type 1: case report and review of the literature. The Turkish journal of pediatrics, 2023, Volume: 65, Issue:5 Topics: Calcium; Child, Preschool; Cinacalcet; Humans; Hypercalcemia; Hypophosphatemia; Male; Mutation; Receptors, Calcium-Sensing	2023
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic. Clinical therapeutics, 2021, Volume: 43, Issue:4 Topics: Bone Density; Calcium; Cinacalcet; COVID-19; Diphosphonates; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Parathyroidectomy; Raloxifene Hydrochloride; Vitamin D	2021
Refractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus-a Case Report and Review of Literature. Journal of gastrointestinal cancer, 2019, Volume: 50, Issue:4 Topics: Calcitonin; Calcium; Calcium-Regulating Hormones and Agents; Carcinoma, Squamous Cell; Cinacalcet; Drug Resistance; Endoscopy, Digestive System; Esophageal Neoplasms; Esophagus; Fatal Outcome; Humans; Hypercalcemia; Male; Middle Aged; Pamidronate; Positron-Emission Tomography	2019
Non-surgical management of primary hyperparathyroidism. Best practice & research. Clinical endocrinology & metabolism, 2018, Volume: 32, Issue:6 Topics: Calcium; Cinacalcet; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Parathyroid Hormone; Parathyroidectomy; Pregnancy; Pregnancy Complications; Vitamin D Deficiency	2018
Management of hypercalcemia after renal transplantation. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6 Topics: Algorithms; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Renal Dialysis; Vitamin D	2013
Primary hyperparathyroidism during pregnancy. Archives of gynecology and obstetrics, 2015, Volume: 291, Issue:2 Topics: Calcitonin; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperplasia; Naphthalenes; Parathyroid Neoplasms; Pregnancy; Pregnancy Complications	2015
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. BMC endocrine disorders, 2015, Jan-28, Volume: 15 Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Cushing Syndrome; Diphosphonates; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperthyroidism; Imidazoles; Male; Parathyroidectomy; Zoledronic Acid	2015
Surgical treatment of persistent hyperparathyroidism after renal transplantation. Annals of surgery, 2008, Volume: 248, Issue:1 Topics: Cinacalcet; Cryopreservation; Diagnostic Imaging; Disease Progression; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Failure, Chronic; Kidney Transplantation; Monitoring, Intraoperative; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Thymectomy	2008
[Cinacalcet - an allosteric enhancer at the Ca2+-receptor]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:33 Topics: Calcium; Cinacalcet; Drug Monitoring; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Receptors, Calcium-Sensing; Renal Dialysis	2008
Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics. The oncologist, 2010, Volume: 15, Issue:1 Topics: Biopsy; Cinacalcet; Diagnostic Imaging; Gene Expression; Humans; Hypercalcemia; Hyperparathyroidism; Immunohistochemistry; Intraoperative Care; Monitoring, Physiologic; Mutation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Prognosis; Risk Factors; Tumor Suppressor Proteins	2010
Medical management of primary hyperparathyroidism with concomitant multiple myeloma. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:6 Topics: Cinacalcet; Diphosphonates; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Multiple Myeloma; Naphthalenes; Pancytopenia; Treatment Outcome	2010
Treatment with calcimimetics in kidney transplantation. Transplantation reviews (Orlando, Fla.), 2010, Volume: 24, Issue:2 Topics: Bone Diseases; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Transplantation; Minerals; Naphthalenes; Postoperative Complications; Survival Analysis; Vitamin D Deficiency	2010
Clinical utilization of cinacalcet in hypercalcemic conditions. Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:4 Topics: Calcimimetic Agents; Cinacalcet; Clinical Trials as Topic; Drug Evaluation; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Receptors, Calcium-Sensing; Renal Dialysis	2011
[Kidney and bone update : the 5-year history and future of CKD-MBD. Parathyroidectomy for secondary hyperparathyroidism]. Clinical calcium, 2012, Volume: 22, Issue:7 Topics: Chronic Disease; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Japan; Kidney Diseases; Naphthalenes; Parathyroidectomy; Practice Guidelines as Topic	2012
Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism. Expert opinion on investigational drugs, 2003, Volume: 12, Issue:8 Topics: Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Receptors, Cell Surface	2003
Calcimimetics versus vitamin D: what are their relative roles? Blood purification, 2004, Volume: 22, Issue:1 Topics: Calcitriol; Cinacalcet; Clinical Trials as Topic; Drug Synergism; Ergocalciferols; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Liver; Naphthalenes; Phosphates; Receptors, Calcitriol; Receptors, Calcium-Sensing; Vitamin D; Vitamin D Deficiency	2004
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2006, Volume: 16, Issue:3 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phosphates; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Renal Dialysis; Vitamin D	2006
Parathyroid cancer. Surgical oncology clinics of North America, 2006, Volume: 15, Issue:3 Topics: Cinacalcet; Humans; Hypercalcemia; Intraoperative Period; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography	2006
The diagnosis and management of asymptomatic primary hyperparathyroidism. Nature clinical practice. Endocrinology & metabolism, 2006, Volume: 2, Issue:9 Topics: Bone Diseases; Cardiovascular Diseases; Cinacalcet; Diphosphonates; Estrogens; Gastrointestinal Diseases; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Glands; Phosphates; Renal Insufficiency	2006
[Hypercalcemia (with treatment)]. La Revue du praticien, 2006, Oct-31, Volume: 56, Issue:16 Topics: Adrenal Cortex Hormones; Aged; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcitriol; Calcium; Cinacalcet; Creatinine; Densitometry; Diphosphonates; Emergencies; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Mutation; Naphthalenes; Parathyroid Hormone; Radionuclide Imaging; Receptors, Calcium-Sensing; Renal Insufficiency; Thyroid Hormones	2006
[Basic and clinical aspects of calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation]. Clinical calcium, 2008, Volume: 18, Issue:1 Topics: Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Naphthalenes; Postoperative Complications; Receptors, Calcium-Sensing	2008

Trials

17 trial(s) available for cinacalcet and Milk-Alkali Syndrome

Article	Year
Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism. Clinical transplantation, 2020, Volume: 34, Issue:8 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies	2020
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:12 Topics: Adult; Aged; Bone Diseases, Metabolic; Calcimimetic Agents; Cinacalcet; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Proportional Hazards Models; Renal Dialysis; Severity of Illness Index	2013
A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:11 Topics: Adult; Bone Density; Bone Remodeling; Calcium; Cinacalcet; Double-Blind Method; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Phosphorus; Placebos	2014
Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery. European journal of endocrinology, 2015, Volume: 172, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Cinacalcet; Contraindications; Double-Blind Method; Endpoint Determination; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Phosphorus	2015
Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2015, Mar-31, Volume: 87, Issue:1 Topics: Aged; Allopurinol; Calcimimetic Agents; Cinacalcet; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Nephrolithiasis; Pilot Projects; Potassium Citrate; Prospective Studies; Treatment Outcome	2015
A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism. Journal of the American Society of Nephrology : JASN, 2016, Volume: 27, Issue:8 Topics: Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Parathyroidectomy; Postoperative Complications; Prospective Studies	2016
Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism. Journal of bone and mineral metabolism, 2017, Volume: 35, Issue:6 Topics: Adult; Aged; Asian People; Calcium; Calcium, Dietary; Cinacalcet; Creatinine; Demography; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Vital Signs	2017
Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation, 2008, Aug-15, Volume: 86, Issue:3 Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone Density; Calcifediol; Calcitriol; Calcium; Cinacalcet; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Prospective Studies; Time Factors; Treatment Outcome	2008
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet. Nephron. Clinical practice, 2009, Volume: 112, Issue:1 Topics: Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D	2009
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:1 Topics: Absorptiometry, Photon; Alkaline Phosphatase; Analysis of Variance; Bone Density; Calcium; Cinacalcet; Double-Blind Method; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphates; Severity of Illness Index; Treatment Outcome	2011
[Low-dose cinacalcet reduces serum calcium in patients with primary hyperparathyroidism not eligible for surgery]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Asthenia; Calcium; Cinacalcet; Contraindications; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Nausea; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Prospective Studies; Vitamin D	2011
[Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation]. Medicina clinica, 2012, Apr-07, Volume: 138, Issue:8 Topics: Adult; Biomarkers; Calcimimetic Agents; Cinacalcet; Collagen; Drug Administration Schedule; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Naphthalenes; Parathyroid Hormone; Peptide Fragments; Treatment Outcome	2012
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:8 Topics: Administration, Intravenous; Administration, Oral; Aged; Bone Density; Bone Density Conservation Agents; Calcium; Cinacalcet; Drug Therapy, Combination; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Receptors, Calcitriol; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D	2012
Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:7 Topics: Aged; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Prospective Studies	2005
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:10 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Quality of Life; Treatment Outcome	2007
Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Transplantation proceedings, 2007, Volume: 39, Issue:7 Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Patient Selection; Prospective Studies	2007
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:7 Topics: Adult; Aged; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Severity of Illness Index; Sterols; Treatment Outcome; Vitamin D	2008

Other Studies

106 other study(ies) available for cinacalcet and Milk-Alkali Syndrome

Article	Year
Amelioration of hypercalcemia by cinacalcet treatment in a subject with relapsing acquired hypocalciuric hypercalcemia: A case report. Medicine, 2021, Oct-22, Volume: 100, Issue:42 Topics: Aged; Calcium-Regulating Hormones and Agents; Cinacalcet; Creatinine; Humans; Hypercalcemia; Male	2021
Successful use of cinacalcet monotherapy in the management of siblings with homozygous calcium-sensing receptor mutation. Journal of pediatric endocrinology & metabolism : JPEM, 2022, Apr-26, Volume: 35, Issue:4 Topics: Calcium; Child; Cinacalcet; Homozygote; Humans; Hypercalcemia; Infant; Infant, Newborn; Mutation; Receptors, Calcium-Sensing; Siblings	2022
Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in Frontiers in endocrinology, 2021, Volume: 12 Topics: Adult; Calcium; Calcium-Regulating Hormones and Agents; Cinacalcet; HEK293 Cells; Humans; Hypercalcemia; Male; Mutation; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Radiofrequency Ablation; Receptors, Calcium-Sensing; Treatment Failure	2021
Personalised medicines for familial hypercalcemia and hyperparathyroidism. Journal of molecular endocrinology, 2022, 05-09, Volume: 69, Issue:1 Topics: Calcium; Cinacalcet; HEK293 Cells; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Mutation; Precision Medicine; Receptors, Calcium-Sensing	2022
The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene. Pediatric endocrinology, diabetes, and metabolism, 2022, Volume: 28, Issue:2 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Male; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing	2022
Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study. Langenbeck's archives of surgery, 2022, Volume: 407, Issue:6 Topics: Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney; Kidney Transplantation; Parathyroid Hormone; Parathyroidectomy	2022
Neurorescuing effect of Cinacalcet against hypercalcemia-induced nerve injury in chronic kidney disease via TRAF2/cIAP1/KLF2/SERPINA3 signal axis. Cell biology and toxicology, 2023, Volume: 39, Issue:5 Topics: Animals; Cinacalcet; Hypercalcemia; Mice; Renal Insufficiency, Chronic; TNF Receptor-Associated Factor 2; Ubiquitin	2023
Refractory paraneoplastic hypercalcaemia responding to cinacalcet. BMJ case reports, 2022, Nov-15, Volume: 15, Issue:11 Topics: Bone Neoplasms; Cinacalcet; Female; Humans; Hypercalcemia; Neoplasm Recurrence, Local; Parathyroid Hormone; Urinary Bladder Neoplasms	2022
Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation. Hormone research in paediatrics, 2023, Volume: 96, Issue:4 Topics: Calcitriol; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hypoparathyroidism; Infant; Infant, Newborn; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing	2023
Pre-operative Cinacalcet Administration Reduces Immediate Post-operative Hypocalcemia Following Total Parathyroidectomy in Severe Renal Hyperparathyroidism. World journal of surgery, 2023, Volume: 47, Issue:8 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies; Treatment Outcome	2023
Neonatal severe hyperparathyroidism: A case report. JPMA. The Journal of the Pakistan Medical Association, 2022, Volume: 72, Issue:12 Topics: Calcium; Child; Cinacalcet; Heterozygote; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Male; Mutation	2022
Resolution of Secondary Hyperparathyroidism After Kidney Transplantation and the Effect on Graft Survival. Annals of surgery, 2023, 09-01, Volume: 278, Issue:3 Topics: Calcium; Cinacalcet; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies	2023
Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report. BMC endocrine disorders, 2023, Jun-16, Volume: 23, Issue:1 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Male; Middle Aged; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Zoledronic Acid	2023
Editorial: Cancer-related hypercalcemia and potential treatments. Frontiers in endocrinology, 2023, Volume: 14 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Neoplasms	2023
Cinacalcet sustainedly prevents pancreatitis in a child with a compound heterozygous SPINK1/AP2S1 mutation. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2019, Volume: 19, Issue:6 Topics: Acute Disease; Adaptor Protein Complex 2; Adaptor Protein Complex sigma Subunits; Adolescent; Calcium-Regulating Hormones and Agents; Cinacalcet; Female; Humans; Hypercalcemia; Mutation; Pancreatitis; Recurrence; Trypsin Inhibitor, Kazal Pancreatic	2019
The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism. Jornal brasileiro de nefrologia, 2019, Jul-18, Volume: 41, Issue:3 Topics: Adult; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vitamin D	2019
A Functional Parathyroid Cyst from the Hemorrhagic Degeneration of a Parathyroid Adenoma. Internal medicine (Tokyo, Japan), 2020, Feb-01, Volume: 59, Issue:3 Topics: Adenoma; Aged; Calcimimetic Agents; Cinacalcet; Cysts; Humans; Hypercalcemia; Hyperparathyroidism; Male; Parathyroid Glands; Parathyroid Neoplasms; Parathyroidectomy; Treatment Outcome	2020
Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy. The British journal of surgery, 2019, Volume: 106, Issue:13 Topics: Aged; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Pilot Projects; Postoperative Period; Quality of Life; Treatment Outcome	2019
Primary Hyperparathyroidism Manifesting with Severe Hypercalcemia in a Nonagenarian Man: Pitfall of Common Imaging Techniques, Localization by 18F-Choline Positron Emission Tomography/Computed Tomography and Successful Management with Calcimimetics. Acta medica (Hradec Kralove), 2019, Volume: 62, Issue:4 Topics: Aged, 80 and over; Calcimimetic Agents; Choline; Cinacalcet; Fluorine Radioisotopes; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Severity of Illness Index	2019
Safety and Efficacy of a 3-Year Therapy With Cinacalcet in Persistent Hyperparathyroidism After Renal Transplant. Transplantation proceedings, 2020, Volume: 52, Issue:5 Topics: Adult; Calcium; Cinacalcet; Drug Administration Schedule; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Postoperative Complications; Retrospective Studies; Time Factors; Treatment Outcome	2020
Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet. BMC endocrine disorders, 2020, Apr-20, Volume: 20, Issue:1 Topics: Adenoma; Biopsy; Calcium-Regulating Hormones and Agents; Cinacalcet; Cysts; Diagnostic Errors; Disease Progression; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Magnetic Resonance Imaging; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Thyroid Diseases; Tumor Burden; Ultrasonography	2020
Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy. Medical hypotheses, 2020, Volume: 143 Topics: Bone Density Conservation Agents; Calcitonin; Calcium; Cinacalcet; Humans; Hypercalcemia	2020
Prediction of cognitive response to surgery in elderly patients with primary hyperparathyroidism. BJS open, 2021, 03-05, Volume: 5, Issue:2 Topics: Adult; Aged; Calcimimetic Agents; Cinacalcet; Cognitive Dysfunction; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroidectomy; Prospective Studies; Treatment Outcome	2021
Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2. Human molecular genetics, 2021, 05-29, Volume: 30, Issue:10 Topics: Adaptor Protein Complex 2; Adaptor Protein Complex sigma Subunits; Animals; Bone Density; Calcium; Cinacalcet; CRISPR-Cas Systems; Disease Models, Animal; Fibroblast Growth Factor-23; Gene Editing; Humans; Hypercalcemia; Mice; Mutation; Phenotype; Receptors, Calcium-Sensing	2021
Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism. Hormones (Athens, Greece), 2021, Volume: 20, Issue:3 Topics: Aged; Calcium; Cinacalcet; Cognitive Dysfunction; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Hormone	2021
Hypercalcemia and Acute Renal Failure Indicating Peritoneal Sarcoidosis. The American journal of medicine, 2021, Volume: 134, Issue:12 Topics: Acute Kidney Injury; Aged, 80 and over; Calcium-Regulating Hormones and Agents; Cinacalcet; Diagnosis, Differential; Glucocorticoids; Humans; Hypercalcemia; Laparoscopy; Lymphadenopathy; Male; Peritoneal Diseases; Peritonitis, Tuberculous; Positron Emission Tomography Computed Tomography; Prednisone; Renal Insufficiency, Chronic; Sarcoidosis; Tomography, X-Ray Computed	2021
Lithium-Induced Hyperparathyroidism: An Ill-defined Territory. Psychopharmacology bulletin, 2021, 06-01, Volume: 51, Issue:3 Topics: Bipolar Disorder; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Lithium	2021
Cinacalcet as symptomatic treatment of hypercalcaemia in primary hyperparathyroidism prior to surgery. Endokrynologia Polska, 2017, Volume: 68, Issue:3 Topics: Adult; Aged; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone	2017
Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2018, Volume: 38, Issue:1 Topics: Adenoma; Adult; Calcimimetic Agents; Cesarean Section; Cinacalcet; Female; Gestational Age; Humans; Hypercalcemia; Hyperthyroidism; Infant, Low Birth Weight; Infant, Newborn; Parathyroid Neoplasms; Pregnancy; Pregnancy Complications	2018
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation. JCI insight, 2017, 10-19, Volume: 2, Issue:20 Topics: Administration, Oral; Animals; Calcium; Cinacalcet; Disease Models, Animal; Ethylnitrosourea; Female; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Hypercalcemia; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Molecular; Mutation; Parathyroid Hormone; Receptors, Calcium-Sensing; Sequence Alignment; Sequence Analysis, DNA; Serum Albumin; Signal Transduction	2017
Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2018, Volume: 16, Issue:3 Topics: Adult; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Drug Administration Schedule; Female; Greece; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypophosphatemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Time Factors; Treatment Outcome	2018
Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS. JAMA, 2018, Jan-02, Volume: 319, Issue:1 Topics: Child; Cinacalcet; Clinical Trials as Topic; Drug Approval; Drug Industry; Drugs, Generic; Government Regulation; Humans; Hypercalcemia; Marketing; Patents as Topic; Pediatrics; United States; United States Food and Drug Administration	2018
Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Renal failure, 2018, Volume: 40, Issue:1 Topics: Aged; Calcimimetic Agents; Calcium; Cinacalcet; Cross-Sectional Studies; Female; Gallstones; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Prevalence; Renal Dialysis; Sex Factors; Time Factors	2018
Large-scale exome datasets reveal a new class of adaptor-related protein complex 2 sigma subunit (AP2σ) mutations, located at the interface with the AP2 alpha subunit, that impair calcium-sensing receptor signalling. Human molecular genetics, 2018, 03-01, Volume: 27, Issue:5 Topics: Adaptor Protein Complex 2; Adaptor Protein Complex alpha Subunits; Adaptor Protein Complex sigma Subunits; Cinacalcet; Databases, Genetic; Exome; Exome Sequencing; Female; Humans; Hypercalcemia; Male; Middle Aged; Models, Molecular; Mutation; Protein Conformation; Receptors, Calcium-Sensing; Signal Transduction	2018
A case of hyperparathyroidism-associated parkinsonism successfully treated with cinacalcet hydrochloride, a calcimimetic. BMC neurology, 2018, May-07, Volume: 18, Issue:1 Topics: Aged, 80 and over; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Middle Aged; Parkinsonian Disorders	2018
[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2018, Volume: 35, Issue:3 Topics: Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Health Services Needs and Demand; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Parathyroid Glands; Parathyroid Hormone; Peptides; Receptors, Calcium-Sensing; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D	2018
Acute pseudogout after cinacalcet treatment. Kidney international, 2018, Volume: 94, Issue:4 Topics: Acute Disease; Aged, 80 and over; Calcimimetic Agents; Calcium; Chondrocalcinosis; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary	2018
Acute severe primary hyperparathyroidism: spontaneous remission after 2 years follow-up. Journal of endocrinological investigation, 2019, Volume: 42, Issue:2 Topics: Calcium-Regulating Hormones and Agents; Cinacalcet; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Remission, Spontaneous; Renal Dialysis; Severity of Illness Index; Treatment Outcome	2019
Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody. JCI insight, 2019, 04-18, Volume: 4, Issue:8 Topics: Aged, 80 and over; Allosteric Regulation; Autoantibodies; Autoantigens; Binding Sites; Calcium; Calcium-Regulating Hormones and Agents; Cinacalcet; HEK293 Cells; Humans; Hypercalcemia; Male; Receptors, Calcium-Sensing; Receptors, G-Protein-Coupled; Severity of Illness Index; Signal Transduction; Treatment Outcome	2019
Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption. JCI insight, 2019, 04-23, Volume: 5 Topics: Animals; Calcimimetic Agents; Calcium; Calcium Channels; Cinacalcet; Disease Models, Animal; Estrenes; Female; Gene Knock-In Techniques; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Intestinal Absorption; Intestinal Mucosa; Kidney Tubules; Male; Mice; Mice, Transgenic; Oocytes; Parathyroid Hormone; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyrrolidinones; Receptors, Calcium-Sensing; TRPV Cation Channels; Type C Phospholipases; Xenopus	2019
Effectiveness and safety of cinacalcet for primary hyperparathyroidism: a single center experience. Endocrine journal, 2019, Aug-29, Volume: 66, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Nausea; Retrospective Studies; Treatment Outcome	2019
Effect of Cinacalcet in Kidney Transplant Patients With Hyperparathyroidism. Transplantation proceedings, 2019, Volume: 51, Issue:5 Topics: Adult; Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Middle Aged; Renal Dialysis; Retrospective Studies	2019
Cinacalcet effect on polymorphonuclear leucocytes of kidney transplant patients. European journal of clinical investigation, 2013, Volume: 43, Issue:5 Topics: Apoptosis; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Neutrophils; Phagocytosis; Respiratory Burst	2013
Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors. European journal of pharmacology, 2013, Jul-15, Volume: 712, Issue:1-3 Topics: Animals; Calcitonin; Calcium; Cell Line, Tumor; Cinacalcet; Colonic Neoplasms; Female; Gene Expression Regulation; Hypercalcemia; Leydig Cell Tumor; Male; Mice; Naphthalenes; Parathyroid Hormone-Related Protein; Rats; Receptors, Calcium-Sensing	2013
Neonatal hypercalcemia due to a homozygous mutation in the calcium-sensing receptor: failure of cinacalcet. Neonatology, 2013, Volume: 104, Issue:2 Topics: Calcimimetic Agents; Cinacalcet; DNA Mutational Analysis; Drug Resistance; Exons; Genetic Predisposition to Disease; Homozygote; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Male; Naphthalenes; Phenotype; Receptors, Calcium-Sensing; Sequence Deletion; Treatment Failure	2013
Evaluation of parathyroid levels and bone densitometry after cinacalcet treatment in severe primary hyperparathyroidism. Minerva endocrinologica, 2013, Volume: 38, Issue:3 Topics: Alkaline Phosphatase; Bone Density; Calcium; Cinacalcet; Diphosphonates; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Ibandronic Acid; Naphthalenes; Osteoporosis; Parathyroid Hormone; Phosphates; Vitamin D	2013
Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study. Nephrology (Carlton, Vic.), 2014, Volume: 19, Issue:2 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Retrospective Studies	2014
Renal replacement therapy as a treatment for severe refractory hypercalcemia. Minerva endocrinologica, 2014, Volume: 39, Issue:3 Topics: Adenoma; Adult; Carcinoma; Cinacalcet; Diphosphonates; Drug Resistance; Emergencies; Female; Furosemide; Hemodiafiltration; Hemofiltration; Humans; Hydroxycholecalciferols; Hypercalcemia; Hypoparathyroidism; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Naphthalenes; Pamidronate; Pancreatitis, Acute Necrotizing; Parathyroid Neoplasms; Parathyroidectomy	2014
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. Endocrine, 2015, Volume: 49, Issue:1 Topics: Adult; Bone Density; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Parathyroid Hormone; Treatment Outcome	2015
Changes in bone mineral metabolism parameters, including FGF23, after discontinuing cinacalcet at kidney transplantation. Endocrine, 2015, Volume: 49, Issue:1 Topics: Adult; Aged; Bone and Bones; Calcimimetic Agents; Calcium; Cinacalcet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypercalcemia; Hypophosphatemia; Kidney Transplantation; Male; Middle Aged; Phosphates; Prospective Studies	2015
A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria. BMC endocrine disorders, 2014, Oct-07, Volume: 14 Topics: Adult; Aged; Blotting, Western; Calcimimetic Agents; Cinacalcet; Genetic Markers; Humans; Hypercalcemia; Hypercalciuria; Male; Naphthalenes; Parathyroid Hormone; Pedigree; Point Mutation; Receptors, Calcium-Sensing; Treatment Outcome	2014
[Primary hyperparathyroidism: new concepts, new recommendations]. Annales d'endocrinologie, 2014, Volume: 75 Suppl 1 Topics: Adult; Aged; Bone Density; Calcium; Cinacalcet; Diphosphonates; Endocrinology; Fractures, Bone; General Surgery; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant; Infant, Newborn; Lithiasis; Middle Aged; Naphthalenes; Nephrocalcinosis; Practice Guidelines as Topic; Risk Factors; Societies, Medical; Vitamin D Deficiency	2014
Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation. BioMed research international, 2015, Volume: 2015 Topics: Calcium; Cinacalcet; Female; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism; Kidney; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies	2015
Cinacalcet Treatment in an Adolescent With Concurrent 22q11.2 Deletion Syndrome and Familial Hypocalciuric Hypercalcemia Type 3 Caused by AP2S1 Mutation. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:7 Topics: Adaptor Protein Complex 2; Adaptor Protein Complex sigma Subunits; Adolescent; Base Sequence; Cinacalcet; DiGeorge Syndrome; Humans; Hypercalcemia; Male; Mutation, Missense; Naphthalenes; Pedigree	2015
Parathyroidectomy or Calcimimetic to Treat Hypercalcemia after Kidney Transplantation? Journal of the American Society of Nephrology : JASN, 2016, Volume: 27, Issue:8 Topics: Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalcemia; Kidney Transplantation; Parathyroid Hormone; Parathyroidectomy	2016
Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders. The Journal of biological chemistry, 2016, May-13, Volume: 291, Issue:20 Topics: Allosteric Regulation; Amino Acid Substitution; Cinacalcet; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Hypercalcemia; Hypocalcemia; Mutation, Missense; Naphthalenes; Receptors, Calcium-Sensing; Signal Transduction	2016
Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations. The New England journal of medicine, 2016, Apr-07, Volume: 374, Issue:14 Topics: Adaptor Protein Complex 2; Adaptor Protein Complex sigma Subunits; Adult; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Male; Middle Aged; Mutation	2016
Treatment of Persistent Hypercalcemia and Hyperparathyroidism With Cinacalcet After Successful Kidney Transplantation. Transplantation proceedings, 2016, Volume: 48, Issue:5 Topics: Adult; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies	2016
Hyperparathyroidism-jaw Tumor Syndrome: An Overlooked Cause of Severe Hypercalcemia. The American journal of the medical sciences, 2016, Volume: 352, Issue:3 Topics: Adenoma; Adult; Calcimimetic Agents; Calcitonin; Calcium; Cinacalcet; Diagnosis, Differential; Female; Fibroma; Humans; Hypercalcemia; Hyperparathyroidism; Jaw Neoplasms; Parathyroid Hormone; Parathyroidectomy; Treatment Outcome	2016
Natural History of Serum Calcium and Parathyroid Hormone Following Renal Transplantation. Transplantation proceedings, 2016, Volume: 48, Issue:10 Topics: Adult; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Retrospective Studies	2016
Use of cinacalcet HCl to achieve the recommended targets of bone metabolism in a patient with therapy-resistant renal hyperparathyroidism. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2008, Volume: 18, Issue:4 Topics: Adult; Bone Diseases, Metabolic; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Treatment Outcome; Weight Gain	2008
Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:11 Topics: Adult; Aged; Calcium; Cinacalcet; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Tacrolimus	2008
Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2009, Volume: 117, Issue:3 Topics: Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Liver Cirrhosis; Middle Aged; Naphthalenes; Parathyroid Neoplasms; Ultrasonography	2009
A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet. European journal of endocrinology, 2008, Volume: 159 Suppl 1 Topics: Administration, Oral; Bone Density Conservation Agents; Cinacalcet; Familial Hypophosphatemic Rickets; Female; Genetic Diseases, X-Linked; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism; Hypertension; Infant; Mutation, Missense; Naphthalenes; Nephrocalcinosis; PHEX Phosphate Regulating Neutral Endopeptidase; Phosphates; Renal Insufficiency	2008
Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation, 2008, Oct-15, Volume: 86, Issue:7 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism; Immunosuppressive Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Postoperative Complications	2008
[Primary hyperparathyroidism. An alternative to the surgery]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:3 Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid	2009
Cinacalcet for hyperparathyroidism in pregnancy and puerperium. Journal of pediatric endocrinology & metabolism : JPEM, 2009, Volume: 22, Issue:8 Topics: Adult; Calcitonin; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Male; Naphthalenes; Postpartum Period; Pregnancy; Pregnancy Complications; Treatment Outcome	2009
Is it my calcium, Doctor? Archives of disease in childhood. Education and practice edition, 2009, Volume: 94, Issue:6 Topics: Calcium; Child; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Kidney Calculi; Naphthalenes; Parathyroid Hormone; Renal Colic; Ultrasonography	2009
Parathyroid gland: cinacalcet-can it control hypercalcemia? Nature reviews. Endocrinology, 2010, Volume: 6, Issue:1 Topics: Cinacalcet; DNA; Humans; Hypercalcemia; Hyperparathyroidism; Naphthalenes; Receptors, Calcium-Sensing	2010
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:1 Topics: Attitude of Health Personnel; Biomarkers; Bone Diseases, Metabolic; Calcium; Chelating Agents; Chronic Disease; Cinacalcet; Evidence-Based Medicine; Glomerular Filtration Rate; Guideline Adherence; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Saudi Arabia; Surveys and Questionnaires; Treatment Outcome; Vitamin D; Vitamin D Deficiency	2010
[Patient with chronic kidney disease and primary or tertiary hyperparathyroidism--case report]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2009, Volume: 27, Issue:162 Topics: Adult; Chronic Disease; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Diseases; Naphthalenes	2009
Cinacalcet in the treatment of intractable hypercalcemia following two neck exploration surgeries for primary hyperparathyroidism. Southern medical journal, 2010, Volume: 103, Issue:3 Topics: Aged, 80 and over; Biomimetic Materials; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Naphthalenes; Parathyroid Neoplasms; Receptors, Calcium-Sensing	2010
Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia. Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:9 Topics: Biomarkers; Calcium; Child; Cinacalcet; Genetic Predisposition to Disease; Humans; Hypercalcemia; Male; Mutation; Naphthalenes; Parathyroid Hormone; Pedigree; Receptors, Calcium-Sensing; Time Factors; Treatment Outcome; Tympanoplasty; Wound Healing	2010
Evaluation of cinacalcet HCl treatment after kidney transplantation. Transplantation proceedings, 2010, Volume: 42, Issue:7 Topics: Adult; Bone and Bones; Cinacalcet; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Patient Selection; Postoperative Complications; Retrospective Studies	2010
Continuation of cinacalcet immediately after renal transplantation: a prospective cohort study. Clinical nephrology, 2010, Volume: 74, Issue:6 Topics: Adult; Biomarkers; Calcimimetic Agents; Calcium; Case-Control Studies; Chi-Square Distribution; Cinacalcet; Drug Administration Schedule; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Netherlands; Parathyroid Hormone; Phosphates; Prospective Studies; Time Factors; Treatment Outcome	2010
Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism. Transplantation proceedings, 2010, Volume: 42, Issue:9 Topics: Absorptiometry, Photon; Adult; Arm Bones; Biomarkers; Bone Density; Calcimimetic Agents; Calcium; Case-Control Studies; Cinacalcet; Female; Hip Joint; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; National Institutes of Health (U.S.); Retrospective Studies; Spine; Time Factors; Treatment Outcome; United States	2010
Cinacalcet in the treatment of hypercalcaemia and control of hyperparathyroidism due to ectopic parathyroid glands. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:1 Topics: Aged, 80 and over; Calcimimetic Agents; Calcitriol; Choristoma; Cinacalcet; Female; Gastrointestinal Diseases; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; Mediastinal Diseases; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi	2011
Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation. Clinical nephrology, 2011, Volume: 75, Issue:3 Topics: Adult; Aged; Analysis of Variance; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Retrospective Studies; Time Factors; Treatment Outcome	2011
Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism. Endocrine, 2011, Volume: 39, Issue:3 Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Cinacalcet; Drug Therapy, Combination; Female; Femur; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Lumbar Vertebrae; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Retrospective Studies	2011
[Cinacalcet impact on calcium homeostasis and bone remodeling in 13 renal transplanted patients with hyperparathyroidism and hypercalcaemia]. Nephrologie & therapeutique, 2012, Volume: 8, Issue:1 Topics: Adult; Aged; Bone Remodeling; Calcium; Cinacalcet; Female; Homeostasis; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Prospective Studies	2012
[The value of selective parathyroid venous sampling for localizing occult parathyroid adenomas]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:1 Topics: Adenoma; Aged; Blood Specimen Collection; Catheterization, Peripheral; Cinacalcet; False Negative Reactions; Female; Goiter, Nodular; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Magnetic Resonance Imaging; Naphthalenes; Neoplasm Recurrence, Local; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Preoperative Care; Radionuclide Imaging; Reoperation; Thyroidectomy; Veins; Vitamin D Deficiency	2012
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. Journal of endocrinological investigation, 2012, Volume: 35, Issue:7 Topics: Aged; Aged, 80 and over; Biomarkers; Cinacalcet; Contraindications; Drug Labeling; European Union; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Maintenance Chemotherapy; Membrane Transport Modulators; Middle Aged; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Parathyroidectomy; Practice Guidelines as Topic; Prospective Studies; Receptors, Calcium-Sensing; Severity of Illness Index	2012
Antilipolytic effect of calcimimetics depends on the allelic variant of calcium-sensing receptor gene polymorphism rs1042636 (Arg990Gly). European journal of human genetics : EJHG, 2012, Volume: 20, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Calcium; Cinacalcet; Genetic Variation; Humans; Hypercalcemia; Middle Aged; Naphthalenes; Polymorphism, Genetic; Receptors, Calcium-Sensing	2012
[Long-term combined treatment with cinacalcet and bisphosphonates in persistent primary hyperparathyroidism after surgery]. Medicina clinica, 2012, May-26, Volume: 138, Issue:15 Topics: Alendronate; Bone Density Conservation Agents; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hypercalciuria; Hyperparathyroidism, Primary; Hyperphosphatemia; Middle Aged; Naphthalenes; Osteoporosis; Postoperative Complications	2012
Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism. The Netherlands journal of medicine, 2012, Volume: 70, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes	2012
Short-term use of cinacalcet in children on regular hemodialysis. Arab journal of nephrology and transplantation, 2012, Volume: 5, Issue:1 Topics: Adolescent; Calcimimetic Agents; Child; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic	2012
Cinacalcet for management of hypercalcemia secondary to calcium-sensing receptor mutation. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2013, Volume: 60, Issue:1 Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Mutation; Naphthalenes; Receptors, Calcium-Sensing	2013
Management of lithium-associated hyperparathyroidism. The Australian and New Zealand journal of psychiatry, 2012, Volume: 46, Issue:6 Topics: Bipolar Disorder; Calcimimetic Agents; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Lithium; Middle Aged; Naphthalenes; Parathyroidectomy; Postoperative Complications	2012
Cognitive decline reversed by cinacalcet. QJM : monthly journal of the Association of Physicians, 2015, Volume: 108, Issue:1 Topics: Aged, 80 and over; Calcimimetic Agents; Cinacalcet; Cognition Disorders; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes	2015
Cinacalcet to prevent parathyrotoxic crises in hypercalcaemic patients awaiting parathyroidectomy. BMJ case reports, 2011, May-10, Volume: 2011 Topics: Adenoma; Adult; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; Middle Aged; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy	2011
Hyperparathyroidism in chronic kidney disease: complexities within the commonplace. Clinical medicine (London, England), 2012, Volume: 12, Issue:4 Topics: Adult; Aged; Cinacalcet; Comorbidity; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Renal Insufficiency, Chronic	2012
Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal. Transplantation proceedings, 2012, Volume: 44, Issue:8 Topics: Adult; Aged; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Creatinine; Drug Administration Schedule; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Time Factors; Treatment Outcome	2012
Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up. Transplantation proceedings, 2012, Volume: 44, Issue:9 Topics: Alkaline Phosphatase; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Transplantation; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Retrospective Studies; Time Factors; Treatment Outcome	2012
Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:12 Topics: Adult; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Naphthalenes; Severity of Illness Index; Treatment Failure	2005
Therapeutic failure of cinacalcet in a renal transplant patient. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:3 Topics: Cinacalcet; Drug Resistance; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Naphthalenes; Parathyroidectomy; Treatment Failure	2006
Looking at calcimimetics impact on hypercalcemia of immobilization: hypotheses and a case study. Hemodialysis international. International Symposium on Home Hemodialysis, 2006, Volume: 10, Issue:1 Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Immobilization; Naphthalenes; Receptors, Calcium-Sensing	2006
Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet. Clinical nephrology, 2006, Volume: 65, Issue:5 Topics: Aged; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Receptors, Calcium-Sensing	2006
Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:10 Topics: Administration, Oral; Alkaline Phosphatase; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome	2006
Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor. Journal of internal medicine, 2006, Volume: 260, Issue:2 Topics: Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Humans; Hypercalcemia; Male; Mutation, Missense; Naphthalenes; Parathyroid Hormone; Receptors, Calcium-Sensing; Time Factors	2006
A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy. Nature clinical practice. Endocrinology & metabolism, 2006, Volume: 2, Issue:5 Topics: Adenocarcinoma; Alcohol Drinking; Biopsy, Fine-Needle; Calcitriol; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Liver Neoplasms; Male; Middle Aged; Naphthalenes; Neck; Neoplasm Metastasis; Parathyroid Hormone; Parathyroid Neoplasms; Radiography; Ultrasonography	2006
Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 48, Issue:5 Topics: Aged; Antimanic Agents; Bipolar Disorder; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Lithium Carbonate; Middle Aged; Naphthalenes; Parathyroid Hormone	2006
Persistent hypercalcemia after parathyroidectomy in an adolescent and effect of treatment with cinacalcet HCl. Clinical chemistry, 2006, Volume: 52, Issue:12 Topics: Adolescent; Calcium; Cinacalcet; Diagnosis, Differential; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus	2006
Lithium hypercalcemia, hyperparathyroidism, and cinacalcet. Kidney international, 2007, Volume: 71, Issue:5 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Lithium Compounds; Naphthalenes; Parathyroid Hormone; Phosphates; Serum Albumin; Treatment Outcome	2007
Cinacalcet-associated cardiogenic shock in a patient with cardiomyopathy. Clinical therapeutics, 2007, Volume: 29, Issue:2 Topics: Calcium; Cardiomyopathies; Cardiotonic Agents; Cinacalcet; Drug Administration Schedule; Heart Failure; Hemofiltration; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Probability; Shock, Cardiogenic	2007
Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1, Issue:2 Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Retrospective Studies	2006
Correction of hypercalcaemia by cinacalcet in familial hypocalciuric hypercalcaemia. Clinical endocrinology, 2008, Volume: 68, Issue:2 Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Naphthalenes	2008